Published in Nephron on January 01, 1991
Increased plasma protein binding of propranolol and chlorpromazine mediated by disease-induced elevations of plasma alpha1 acid glycoprotein. N Engl J Med (1978) 2.68
Hemodialysis versus peritoneal dialysis: a comparison of adjusted mortality rates. Am J Kidney Dis (1997) 2.63
Carcinoid tumors: analysis of prognostic factors and survival in 301 patients from a referral center. Ann Oncol (1997) 2.46
Pancreatico-duodenal allotransplantation: experimental and clinical experience. Ann Surg (1970) 2.44
Reduced food intake after jejunoileal bypass: a possible association with prolonged gastric emptying and altered gut hormone patterns. Am J Clin Nutr (1997) 2.27
Dialysis discontinuation. A 'good' death? Arch Intern Med (1995) 2.00
Epidemiology of haemoglobin disorders in Europe: an overview. Scand J Clin Lab Invest (2007) 1.85
Increased incidence of malignancy during chronic renal failure. Lancet (1975) 1.79
Family tension in the search for a kidney donor. JAMA (1971) 1.77
Protein binding of diphenylhydantoin and desmethylimipramine in plasma from patients with poor renal function. N Engl J Med (1971) 1.76
Dialysis discontinuation and palliative care. Am J Kidney Dis (2000) 1.59
Intracerebroventricular infusion of nerve growth factor in three patients with Alzheimer's disease. Dement Geriatr Cogn Disord (1998) 1.55
Spontaneous tendon ruptures in patients on chronic dialysis. Am J Kidney Dis (1996) 1.55
Chlorinated urban water: a cause of dialysis-induced hemolytic anemia. Science (1973) 1.49
Clinical and genetic features of adrenocortical lesions in multiple endocrine neoplasia type 1. J Clin Endocrinol Metab (1992) 1.47
Kinetics of diphenylhydantoin in uraemic patients: consequences of decreased plasma protein binding. Eur J Clin Pharmacol (1974) 1.44
Steroid diabetes in renal transplant recipients: pathogenetic factors and prognosis. Surgery (1973) 1.43
Racial, sexual and age inequalities in chronic dialysis. Nephron (1987) 1.41
Renal failure after eating "magic" mushrooms. CMAJ (1992) 1.40
Who should decide about your death? JAMA (1992) 1.39
Uremic pericardial effusion. Treatment by catheter drainage and local nonabsorbable steroid administration. Nephron (1976) 1.39
Plasma concentrations of calcitonin gene-related peptide in fluid overload. Lancet (1991) 1.39
Gastrointestinal hormones and gastric emptying 20 years after jejunoileal bypass for massive obesity. Int J Obes Relat Metab Disord (1997) 1.33
A simple method for anticoagulation during pre- and postoperative hemodialysis, avoiding rebound phenomenon. Surgery (1972) 1.30
Cough and bronchoconstriction mediated by capsaicin-sensitive sensory neurons in the guinea-pig. Pulm Pharmacol (1988) 1.30
Prevention of urological complications after kidney transplantation. Ann Surg (1971) 1.29
Stopping long-term dialysis. An empirical study of withdrawal of life-supporting treatment. N Engl J Med (1986) 1.28
Renal transplantation in high-risk patients. Arch Surg (1971) 1.28
Neuropeptide expression in rat dorsal root ganglion cells and spinal cord after peripheral nerve injury with special reference to galanin. Neuroscience (1989) 1.26
Renal transplantation in children ages 1 to 5 years. Pediatrics (1978) 1.25
Development of diabetic vascular lesions in normal kidneys transplanted into patients with diabetes mellitus. N Engl J Med (1976) 1.21
Microflora modulates endocrine cells in the gastrointestinal mucosa of the rat. Gastroenterology (1994) 1.21
Importance of small bowel peptides for the improved glucose metabolism 20 years after jejunoileal bypass for obesity. Obes Surg (1998) 1.20
Acute fulminant Wegener granulomatosis. Therapy with immunosuppression, hemodialysis, and renal transplantation. Arch Intern Med (1974) 1.18
A new subcutaneous arteriovenous shunt: applicable in cases where the standard Quinton-Scribner shunt and arteriovenous fistula have failed. Surgery (1973) 1.16
Complications of percutaneous femoral vein catheterizations for hemodialysis. Clin Nephrol (1975) 1.16
Methods for long-term 17β-estradiol administration to mice. Gen Comp Endocrinol (2011) 1.15
Pulmonary complications in transplant recipients. Arch Surg (1972) 1.15
Prediction of early death in end-stage renal disease patients starting dialysis. Am J Kidney Dis (1997) 1.13
Pseudorejection: factors mimicking rejection in renal allograft recipients. Ann Surg (1977) 1.13
The treatment of diabetic kidney disease. Diabetologia (1979) 1.13
Renal transplantation in patients over 50 years of age. Transplant Proc (1981) 1.12
Protein binding of drugs in uremic and normal serum: the role of endogenous binding inhibitors. Biochem Pharmacol (1976) 1.12
Suppressed kindling epileptogenesis in mice with ectopic overexpression of galanin. Proc Natl Acad Sci U S A (2001) 1.11
Influence of angiotensin converting enzyme inhibition on relation of atrial natriuretic peptide concentration to atrial pressure in heart failure. Br Heart J (1994) 1.11
Concentration of substance P, neurokinin A, calcitonin gene-related peptide, neuropeptide Y and vasoactive intestinal polypeptide in synovial fluid from knee joints in patients suffering from rheumatoid arthritis. Scand J Rheumatol (1991) 1.10
Renal allograft rejection simulated by arterial stenosis. Surgery (1970) 1.10
Treatment of an infant with severe chloramphenicol intoxication using charcoal-column hemoperfusion. J Pediatr (1980) 1.09
On the influence of sample size on the prognostic accuracy and reproducibility of renal transplant biopsy. Nephrol Dial Transplant (1998) 1.09
Hemodialysis in Canada: a first-class medical crisis. CMAJ (1994) 1.08
Clinical use of high doses of furosemide (Lasix) in the treatment of resistant nephrotic edema. Acta Med Scand (1968) 1.08
Hemolysis in dialized patients caused by chloramines. Nephron (1974) 1.07
Bilateral changes of substance P-, neurokinin A-, calcitonin gene-related peptide- and neuropeptide Y-like immunoreactivity in rat knee joint synovial fluid during acute monoarthritis. Neurosci Lett (1993) 1.07
Treatment of severe hypophosphatemia. Ann Intern Med (1978) 1.07
Acute tubular necrosis after renal transplantation. Transplantation (1980) 1.06
Dying well after discontinuing the life-support treatment of dialysis. Arch Intern Med (2000) 1.05
Kinetics of morphine in patients with renal failure. Eur J Clin Pharmacol (1987) 1.04
Renal transplantation in patients with insulin-dependent diabetes. Lancet (1973) 1.04
Sensory stimulation (acupuncture) increases the release of calcitonin gene-related peptide in the saliva of xerostomia sufferers. Neuropeptides (1999) 1.04
Sodium ramping in hemodialysis: a study of beneficial and adverse effects. Am J Kidney Dis (1997) 1.04
Ten year experience with renal transplantation in juvenile onset diabetics. Ann Surg (1979) 1.04
The management of life-threatening hyperammonemia: a comparison of several therapeutic modalities. J Pediatr (1980) 1.04
Autoradiographic quantitation and anatomical mapping of 125I-galanin binding sites in the rat central nervous system. J Chem Neuroanat (1989) 1.03
Acute renal failure in infants and children: outcome of 53 patients requiring hemodialysis treatment. J Pediatr (1978) 1.02
Renal disease in infectious mononucleosis. Clin Nephrol (1978) 1.02
Prevention of death after renal transplantation. I. Recognizable patterns leading to death in long-term survivors. Am J Surg (1970) 1.02
Mortality and morbidity in diabetic patients accepted for renal transplantation. Proc Eur Dial Transplant Assoc (1972) 1.01
Letter: Increased serum creatinine resulting from hyperglycemia, mimicking transplant rejection. Ann Intern Med (1975) 1.00
Survival rates of 2,728 patients with end-stage renal disease. Mayo Clin Proc (1984) 0.99
Increased levels of substance P and calcitonin gene-related peptide in rat adjuvant arthritis. A combined immunohistochemical and radioimmunoassay analysis. Arthritis Rheum (1995) 0.99
Impaired plasma protein binding of phenytoin in uremia and displacement effect of salicylic acid. Clin Pharmacol Ther (1976) 0.98
Etiology and prognosis in acute post-transplant renal failure. Am J Med (1976) 0.97
Peptic ulcer disease in the transplant recipient. Arch Surg (1974) 0.97
Radiologic contrast-induced nephropathy. Med Clin North Am (1984) 0.96
Salivary cortisol and administration of concentrated oral glucose in newborn infants: improved detection limit and smaller sample volumes without glucose interference. Scand J Clin Lab Invest (2004) 0.96
Tachykinins and calcitonin gene-related peptide as co-transmitters in local motor responses produced by sensory nerve activation in the guinea-pig isolated renal pelvis. Neuroscience (1992) 0.96
Oxazepam disposition in uremic patients. Acta Pharmacol Toxicol (Copenh) (1977) 0.96
Intractable uraemic pericardial effusion. Proc Eur Dial Transplant Assoc (1973) 0.95
Binding of amobarbital, pentobarbital and diphenylhydantoin to blood cells and plasma proteins in healthy volunteers and uraemic patients. Eur J Clin Pharmacol (1975) 0.95
Mortality, morbidity, and life satisfaction in the very old dialysis patient. Trans Am Soc Artif Intern Organs (1984) 0.95
Are malignancies increased in uremia? Nephron (1979) 0.94
Inherited, non-spherocytic haemolysis due to deficiency of glucose-6-phosphate dehydrogenase. Scand J Clin Lab Invest (2007) 0.94
Neurotransmitters, neuropeptides and binding sites in the rat mediobasal hypothalamus: effects of monosodium glutamate (MSG) lesions. Exp Brain Res (1989) 0.94
Protein binding of diazepam and digitoxin in uremic and normal serum. Biochem Pharmacol (1979) 0.94
Tachykinin antagonists inhibit nerve-mediated contractions in the circular muscle of the human ileum. Involvement of neurokinin-2 receptors. Gastroenterology (1992) 0.94
Dialysis therapy for psoriasis. JAMA (1978) 0.94
GLP-1 suppresses gastrointestinal motility and inhibits the migrating motor complex in healthy subjects and patients with irritable bowel syndrome. Neurogastroenterol Motil (2008) 0.93
Glucuronidation of codeine and morphine in human liver and kidney microsomes: effect of inhibitors. Pharmacol Toxicol (1990) 0.93
Treatment of malignant midgut carcinoid tumours with a long-acting somatostatin analogue octreotide. Acta Oncol (1991) 0.92
Distal small bowel hormones: correlation with fasting antroduodenal motility and gastric emptying. Dig Dis Sci (1998) 0.92
Co-variation of neuropeptide Y, calcitonin gene-related peptide, substance P and neurokinin A in joint fluid from patients with temporomandibular joint arthritis. Arch Oral Biol (1995) 0.92
Regional differences in the motor response to capsaicin in the guinea-pig urinary bladder: relative role of pre- and postjunctional factors related to neuropeptide-containing sensory nerves. Neuroscience (1988) 0.92
Severe renal failure in multiple myeloma. Clin Nephrol (1981) 0.92
Acute renal insufficiency complicating major cardiovascular surgery. Ann Surg (1975) 0.91
Endogenous prostaglandins and microflora modulate DNA synthesis and neuroendocrine peptides in the rat gastrointestinal tract. Scand J Gastroenterol (1997) 0.91
Results of renal transplantation in 100 children. Surgery (1974) 0.91
Postmenopausal women with vasomotor symptoms have increased urinary excretion of calcitonin gene-related peptide. Maturitas (1998) 0.91
Increased concentration of calcitonin gene-related peptide in cerebrospinal fluid of depressed patients. A possible trait marker of major depressive disorder. Neurosci Lett (1994) 0.90
Potent anti-inflammatory action of calcitonin gene-related peptide. Biochem Biophys Res Commun (1991) 0.90